PRED MILD
Details
- Status
- Prescription
- First Approved
- 1972-11-10
- Routes
- OPHTHALMIC
- Dosage Forms
- SUSPENSION/DROPS
PRED MILD Approval History
What PRED MILD Treats
4 indicationsPRED MILD is approved for 4 conditions since its original approval in 1972. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Allergic Disorder
- Inflammatory Disorder
- Chemical Burn
- Thermal Burn
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PRED MILD FDA Label Details
ProIndications & Usage
FDA Label (PDF)PRED MILD ® is indicated for the treatment of mild to moderate noninfectious allergic and inflammatory disorders of the lid, conjunctiva, cornea, and sclera (including chemical and thermal burns).
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.